Cell Cycle
-
MK-8745
Catalog No. A13396 -
TC-A-2317 HCl
Catalog No. A13567 Aurora kinase A 抑制剂TC-A-2317 HCl是一种有效的Aurora激酶A抑制剂(Ki = 1.2 nM,而抑制Aurora激酶B则为101 nM)。选择性超过60种其他激酶(IC50值> 1000 nM)。表现出良好的细胞通透性和抗肿瘤活性。 了解更多 -
SCH-1473759
Catalog No. A14059 -
SCH-1473759 hydrochloride
Catalog No. A21711 Aurora inhibitorSCH-1473759 hydrochloride is an aurora inhibitor with IC50s of 4 and 13 nM for aurora A and B, respectively. 了解更多 -
Aurora Kinase Inhibitor 3
Catalog No. A19448 Aurora A kinase inhibitorAurora Kinase Inhibitor 3 is a strong and selective Aurora A kinase inhibitor with an IC50 of 42 nM, and weakly inhibits EGFR with an IC50>10 μM. 了解更多 -
Aurora inhibitor 1
Catalog No. A19637 Aurora inhibitorAurora inhibitor 1 is a potent Aurora inhibitor with an IC50 of ?? 4 nM and ??13 nM for Aurora A and Aurora B kinase, respectively. 了解更多 -
Hesperadin
Catalog No. A10448 Aurora B Kinase 抑制剂Hesperadin是一种人极光B抑制剂,IC50为40 nM,用于防止底物磷酸化。它显著降低AMPK、Lck、MKK1、MAPKAP-K1、CHK1和PHK的活性,而不抑制MKK1在体内的活性。 了解更多 -
Danusertib (PHA-739358)
Catalog No. A10715 Aurora 抑制剂Danusertib (PHA-739358)是Aurora A/B/C的Aurora激酶抑制剂,在无细胞分析中的IC50为13 nM/79nM/61 nM,对Abl,TrkA,c-RET和FGFR1以及更低的浓度具有中等效力 对Lck,VEGFR2/3,c-Kit,CDK2等有效。 了解更多 -
MK-5108 (VX-689)
Catalog No. A11410 Aurora A Kinase 抑制剂MK-5108,也称为VX-689,是Aurora A激酶ATP结合位点的竞争性抑制剂。 了解更多 -
VX-680 (MK-0457, Tozasertib)
Catalog No. A10981 Aurora Kinase 抑制剂VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。 了解更多 -
AZD1152-HQPA (Barasertib)
Catalog No. A10109 Aurora Kinase B 抑制剂AZD1152-HQPA (Barasertib)是Aurora B的高效抑制剂,Ki值分别为0.36(Aurora B)和1369 nM(Aurora A),与一组其他50种激酶相比具有很高的特异性。 了解更多 -
MLN8237 (Alisertib)
Catalog No. A10004 Aurora A Kinase 抑制剂MLN8237 (Alisertib)是一种选择性Aurora A抑制剂,在无细胞分析中的IC50为1.2 nM。它对Aurora A的选择性比Aurora B高200倍以上。 了解更多 -
SNS-032 (BMS-387032)
Catalog No. A10850 CDK 抑制剂SNS-032(BMS-387032)是细胞周期蛋白依赖性激酶(Cdks)2、7和9的高度选择性和有效抑制剂,具有体外生长抑制作用,并具有诱导恶性B细胞凋亡的能力。 了解更多 -
Flavopiridol HCl
Catalog No. A11045 -
JNJ-7706621
Catalog No. A10494 CDK/Aurora A/B 抑制剂JNJ-7706621是对CDK1/2具有最高效力的pan-CDK抑制剂,IC50为9 nM/4 nM,并且在无细胞分析中对CDK1/2的选择性是CDK3/4/6的6倍以上。它还能有效抑制极光A/B,对Plk1和Wee1没有活性。 了解更多 -
PHA-848125 (Milciclib)
Catalog No. A11047 CDK 抑制剂PHA-848125 (Milciclib)是一种有效的,ATP竞争性CDK抑制剂,作用于CDK2,IC50为45 nM,作用于CDK2比作用于CDK1,2,4,5和7选择性高3倍以上。 了解更多 -
AZD5438
Catalog No. A11105 -
BMS-265246
Catalog No. A11154 -
AT7519 HCl
Catalog No. A11313 -
Purvalanol B
Catalog No. A12352 CDK 抑制剂Purvalanol B是一种细胞周期蛋白依赖性激酶抑制剂。对于cdc2/cyclin B,cdk2/cyclin A,cdk2/cyclin E,cdk4/cyclin D1和cdk5-p35的ic50值分别为6、6、9、> 10,000和6 nm。对一系列其他蛋白激酶具有选择性(IC50 > 10,000 nM)。 了解更多 -
Wogonin
Catalog No. A12216 -
TG-02 (SB1317)
Catalog No. A11962 -
NU6027
Catalog No. A14136 -
Voruciclib
Catalog No. A14392 -
CA-224
Catalog No. A14414 -
NSC 663284
Catalog No. A13524 Cdc25 抑制剂NSC 663284是所有Cdc25同工型的有效,细胞可渗透且不可逆的抑制剂,首选Cdc25A(对于Cdc25A,Cdc25B2和Cdc25C,IC50分别为29、95和89 nM)。 了解更多